186 related articles for article (PubMed ID: 31968688)
1. The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness.
Felipe-Abrio B; Carnero A
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968688
[TBL] [Abstract][Full Text] [Related]
2. c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Carnero A
Mol Oncol; 2019 Jul; 13(7):1519-1533. PubMed ID: 31066170
[TBL] [Abstract][Full Text] [Related]
3. Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Sáez C; Carnero A
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781655
[TBL] [Abstract][Full Text] [Related]
4. Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor.
Mori S; Bernardi R; Laurent A; Resnati M; Crippa A; Gabrieli A; Keough R; Gonda TJ; Blasi F
PLoS One; 2012; 7(10):e39723. PubMed ID: 23056166
[TBL] [Abstract][Full Text] [Related]
5. Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer.
George B; Horn D; Bayo P; Zaoui K; Flechtenmacher C; Grabe N; Plinkert P; Krizhanovsky V; Hess J
Cancer Lett; 2015 Mar; 358(2):191-199. PubMed ID: 25543088
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar protein, Myb-binding protein 1A, specifically binds to nonacetylated p53 and efficiently promotes transcriptional activation.
Ono W; Akaogi K; Waku T; Kuroda T; Yokoyama W; Hayashi Y; Kimura K; Kishimoto H; Yanagisawa J
Biochem Biophys Res Commun; 2013 May; 434(3):659-63. PubMed ID: 23583237
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal stress induces processing of Mybbp1a and its translocation from the nucleolus to the nucleoplasm.
Yamauchi T; Keough RA; Gonda TJ; Ishii S
Genes Cells; 2008 Jan; 13(1):27-39. PubMed ID: 18173745
[TBL] [Abstract][Full Text] [Related]
8. MYBBP1a is a novel repressor of NF-kappaB.
Owen HR; Elser M; Cheung E; Gersbach M; Kraus WL; Hottiger MO
J Mol Biol; 2007 Feb; 366(3):725-36. PubMed ID: 17196614
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and chromosomal mapping of the human homologue of MYB binding protein (P160) 1A (MYBBP1A) to 17p13.3.
Keough R; Woollatt E; Crawford J; Sutherland GR; Plummer S; Casey G; Gonda TJ
Genomics; 1999 Dec; 62(3):483-9. PubMed ID: 10644447
[TBL] [Abstract][Full Text] [Related]
10. Growth of pancreatic cancers with hemizygous chromosomal 17p loss of
Hsieh A; Pitarresi JR; Lerner J; Donahue G; Hsiehchen D; Rustgi AK; Zaret K
Sci Adv; 2020 Dec; 6(49):. PubMed ID: 33277249
[TBL] [Abstract][Full Text] [Related]
11. Myb-binding protein 1a is a nucleocytoplasmic shuttling protein that utilizes CRM1-dependent and independent nuclear export pathways.
Keough RA; Macmillan EM; Lutwyche JK; Gardner JM; Tavner FJ; Jans DA; Henderson BR; Gonda TJ
Exp Cell Res; 2003 Sep; 289(1):108-23. PubMed ID: 12941609
[TBL] [Abstract][Full Text] [Related]
12. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK.
Fan M; Rhee J; St-Pierre J; Handschin C; Puigserver P; Lin J; Jäeger S; Erdjument-Bromage H; Tempst P; Spiegelman BM
Genes Dev; 2004 Feb; 18(3):278-89. PubMed ID: 14744933
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of H3K18 deacetylation of Sirt7 by Myb-binding protein 1a (Mybbp1a).
Karim MF; Yoshizawa T; Sato Y; Sawa T; Tomizawa K; Akaike T; Yamagata K
Biochem Biophys Res Commun; 2013 Nov; 441(1):157-63. PubMed ID: 24134843
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition.
Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Palacios-Zambrano S; Moreno-Villa MR; Ruiz-Valdepeñas AM; Lendinez C; Romero A; Franco F; Calvo V; Alfaro C; Acosta PM; Salas C; Garcia JM; Provencio M
Free Radic Biol Med; 2019 May; 135():167-181. PubMed ID: 30880247
[TBL] [Abstract][Full Text] [Related]
15. The role of ANK interactions with MYBBP1a and SPHK1 in catabolic events of articular chondrocytes.
Minashima T; Campbell KA; Hadley SR; Zhang Y; Kirsch T
Osteoarthritis Cartilage; 2014 Jun; 22(6):852-61. PubMed ID: 24747173
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
17. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
[TBL] [Abstract][Full Text] [Related]
19. TPPII, MYBBP1A and CDK2 form a protein-protein interaction network.
Nahálková J; Tomkinson B
Arch Biochem Biophys; 2014 Dec; 564():128-35. PubMed ID: 25303791
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.
Zacksenhaus E; Shrestha M; Liu JC; Vorobieva I; Chung PED; Ju Y; Nir U; Jiang Z
Trends Cancer; 2017 Nov; 3(11):768-779. PubMed ID: 29120753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
